Month: <span>April 2022</span>

Home / 2022 / April
Cause of metastasis in prostate cancer discovered
Post

Cause of metastasis in prostate cancer discovered

by Johannes Angerer, Medical University of Vienna KMT2C methyltransferase deficiency triggers metastatic dissemination of prostate cancer. a H&E stains of urinary tract obstruction by invasive PCa in a moribund Pten∆/∆Kmt2cSET∆/∆ mouse at 39 weeks p.p. at low (top) and high (bottom) magnification. Scale bars: 200 µm. T, tumor; U, urethra. b H&E-stained sections and IHC analysis of the...

The quest to prevent MS — and understand other post-viral diseases
Post

The quest to prevent MS — and understand other post-viral diseases

Asher Mullard A small number of people infected with Epstein-Barr virus (pictured) go on to develop multiple sclerosis years later. Credit: Dr Gopal Murti/SPL In a sprawling facility in Silver Spring, Maryland, the US Department of Defense (DoD) has amassed a hoard of epidemiological treasure. Walk-in freezers each the size of a basketball court hold...

How new endometriosis guidelines will improve diagnosis, treatment
Post

How new endometriosis guidelines will improve diagnosis, treatment

Endometriosis is a common gynecological condition that affects thousands of girls and women. Catherine McQueen/Getty Images Researchers in Europe have created new guidelines for diagnosing and treating endometriosis. They have made significant updates to five key areas in managing the condition, including diagnosis, treatment, and recurrence. The new guidelines could help patients and clinicians better...

Post

Targeting Cellular Senescence as a Basis for Treating Osteoporosis

Senescent cells accumulate with age, causing tissue dysfunction throughout the body via their inflammatory secretions. One of those dysfunctions is the age-related imbalance in bone remodeling, favoring the osteoclasts that break down bone tissue at the expense of the osteoblasts that rebuild it. The result is osteoporosis, the characteristic loss of bone mass and resilience that...

Five minutes of daily breath training improves exercise tolerance in middle-aged and older adults
Post

Five minutes of daily breath training improves exercise tolerance in middle-aged and older adults

EXPERIMENTAL BIOLOGY IMAGE: KAITLIN A. FREEBERG, MS CREDIT: KAITLIN A. FREEBERG, MS Philadelphia (April 2, 2022)—Despite the myriad known benefits of exercise, many middle-aged and older adults struggle to meet physical activity recommendations. New research finds potential for high-resistance inspiratory muscle strength training (IMST) to help this population transition to a healthier lifestyle. The study...

Post

Cleveland Clinic-led trial shows drug effective in nearly 80% of patients with hypertrophic cardiomyopathy

CLEVELAND CLINIC EMBARGOED UNTIL 9:30A.M. ET., Saturday, April 2nd, 2022, Cleveland: Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.   The trial evaluated whether the drug, mavacamten, could be used as an alternative to heart surgery...

Immune system ‘sentinel’ cells key to maintaining and regulating response to immunotherapy
Post

Immune system ‘sentinel’ cells key to maintaining and regulating response to immunotherapy

by University of Melbourne A part of the spleen during chronic viral infection. Dendritic cells are green, killer T cells are red, B cells are blue and stromal cells are magenta. Credit: Würzburg Institute of Systems Immunology, Max-Planck Research Group. The presence of dendritic cells, so-called ‘sentinel’ immune cells, is vital to maintain and regulate...

Pfizer inflammatory disease drug hits goal in second study
Post

Pfizer inflammatory disease drug hits goal in second study

Published March 29, 2022 Ned Pagliarulo Lead Editor Jeenah Moon via Getty Images Dive Brief: An experimental inflammatory disease drug acquired by Pfizer earlier this year met all of its goals in the second of two late-stage trials testing its potential in treating ulcerative colitis, a chronic bowel disease that affects millions of people in the U.S....